Author:
Takami Mitsutaka,Tsukada Wataru
Reference33 articles.
1. DP-1904, a novel thromboxane A2(TXA2) synthetase inhibitor attenuates the effect of inflammatory mediators in human monocytes and lymphocytes;Agrawal;Am. Rev. Respir. Dis.,1993
2. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation;Agrawal;Inflammation,1997
3. Bronchial anaphylaxis in actively sensitized Sprague–Dawley rats: studies on mediators involves;Dahlback;Acta Pharmacol. Toxicol.,1984
4. Thromboxane synthetase inhibition in allergen challenged sheep lung: effect on eicosanoid synthesis;Dworski;Eicosanoids,1992
5. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects;Fujimura;Thorax,1986